Strategic Imperatives of the Life Sciences Industry


Delivering consistent Business performance while balancing patent expiry, expediting new drug launch, continuously evolving regulatory landscape along with pricing pressure to address the unmet needs for their patients are driving biopharma towards a large scale digital adoption across value chain.

Demand for outcomes at minimum cost and for patient safety are driving organizations to leverage technology. These technologies and capabilities – like big data and analytics, artificial intelligence (AI), digital, cloud and mobility technologies – are re-defining the way organizations conduct their business.

Mobile app and Wearables based virtual interactions and monitoring, and cloud based services with enhanced algorithms for behavioral analytics to keep them engaged are now a reality. Such disruptive digital solutions go a long way in enhancing patient experience.

A New Way of Patient Experience in Clinical Trials


Infosys Life Sciences Practice enables organizations in this industry to maximize returns on technology investments and to help them achieve the "Patient First" paradigm.

How we do this: We map the patient perspective to technology capabilities by bringing together design thinking, deep industry knowledge and host of next generation platforms that can help constantly innovate and invent new business models

Strategic Imperatives of the Life Sciences Industry

Strategic Imperatives of the Life Sciences Industry